Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

Reducing antibiotic use in primary care may be insufficient alone to curtail antimicrobial resistance

Medical Xpress reported on the recent findings...

17-year-old makes color changing sutures that detect infection

Recently the PBS News Hour featured an episode...

Antibiotic combinations may boost resistance, study finds

Becker’s Hospital Review recently reported on a...

Pharma ‘cash call’ for new antibiotics

More than 80 pharmaceutical companies have...

Antibiotic resistance: World on cusp of ‘post antibiotic era’

The world is on the cusp of a "post-antibiotic...

Principal causes for hospital readmission identified

A group of physicians in Canada examined a...

New treatment for drug-resistant bacterial infections

ScienceDaily has recently reported on a study by...

CDC to spend $2.1B to bolster US infection control and prevention efforts

Becker’s Hospital Review recently reported on...

La resistencia a los antibióticos puede extenderse en ausencia de medicamentos.

Medical News Today informó recientemente sobre...

Articulación de rodilla infectada

Cortesía del Dr. Donald W....